|
Originally published In Press as doi:10.1074/jbc.M109973200 on December 20, 2001
J. Biol. Chem., Vol. 277, Issue 8, 6688-6695, February 22, 2002
Versatile Biosynthetic Engineering of Sialic Acid in Living Cells
Using Synthetic Sialic Acid Analogues*
Cornelia
Oetke ,
Reinhard
Brossmer§¶,
Lars R.
Mantey ,
Stephan
Hinderlich ,
Rainer
Isecke§**,
Werner
Reutter ,
Oliver T.
Keppler  , and
Michael
Pawlita §§
From the Angewandte Tumorvirologie, Deutsches
Krebsforschungszentrum, Im Neuenheimer Feld 280, § Biochemie-Zentrum, Ruprecht-Karls-Universität
Heidelberg, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany and
Institut für Molekularbiologie und Biochemie, Freie
Universität Berlin, Arnimallee 22, D-14195 Berlin-Dahlem, Germany
Sialic acids are critical components of many
glycoconjugates involved in biologically important ligand-receptor
interactions. Quantitative and structural variations of sialic acid
residues can profoundly affect specific cell-cell, pathogen-cell, or
drug-cell interactions, but manipulation of sialic acids in mammalian
cells has been technically limited. We describe the finding of a
previously unrecognized and efficient uptake and incorporation of
sialic acid analogues in mammalian cells. We added 16 synthetic sialic acid analogues carrying distinct C-1, C-5, or C-9 substitutions individually to cell cultures of which 10 were readily taken up and
incorporated. Uptake of C-5- and C-9-substituted sialic acids resulted
in the structural modification of up to 95% of sialic acids on the
cell surface. Functionally, binding of murine sialic acid-binding
immunoglobulin-like lectin-2 (Siglec-2, CD22) to cells increased after
N-glycolylneuraminic acid treatment, whereas 9-iodo-N-acetylneuraminic acid abolished binding.
Furthermore, susceptibility to infection by the B-lymphotropic
papovavirus via a sialylated receptor was markedly enhanced following
pretreatment of host cells with selected sialic acid analogues
including 9-iodo-N-acetylneuraminic acid. This novel
experimental strategy allows for an efficient biosynthetic engineering
of surface sialylation in living cells. It is versatile, extending the
repertoire of modification sites at least to C-9 and enables detailed
structure-function studies of sialic acid-dependent
ligand-receptor interactions in their native context.
*
This work was supported by the Sonnenfeld-Stiftung, Berlin,
Germany, the Fonds der Chemischen Industrie, Frankfurt/Main, Germany, the Wilhelm Sander-Stiftung, München, Germany, and the Human Frontier Science Program, Strasbourg, France.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence may be addressed: Biochemie-Zentrum,
Universität Heidelberg, Im Neuenheimer Feld 328, D-69120
Heidelberg, Germany. Tel.: 49-6221-544170; Fax: 49-6221-545586; E-mail:
reinhard.brossmer@urz.uni-heidelberg.de.
**
Present address: CHESS GmbH, Dr.-Albert-Reimann-Str. 2, D-68526
Ladenburg, Germany.

Present address: Gladstone Institute of Virology and
Immunology, P. O. Box 419100, San Francisco, CA 94141-9100.
§§
To whom correspondence may be addressed: Deutsches
Krebsforschungszentrum, ATV F0200, Im Neuenheimer Feld 280, D-69120
Heidelberg. Tel.: 49-6221-424645; Fax: 49-6221-424932; E-mail:
m.pawlita@dkfz.de.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. E. Collins, O. Blixt, S. Han, B. Duong, H. Li, J. K. Nathan, N. Bovin, and J. C. Paulson
High-Affinity Ligand Probes of CD22 Overcome the Threshold Set by cis Ligands to Allow for Binding, Endocytosis, and Killing of B Cells.
J. Immunol.,
September 1, 2006;
177(5):
2994 - 3003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bardor, D. H. Nguyen, S. Diaz, and A. Varki
Mechanism of Uptake and Incorporation of the Non-human Sialic Acid N-Glycolylneuraminic Acid into Human Cells
J. Biol. Chem.,
February 11, 2005;
280(6):
4228 - 4237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Benie, A. Blume, R. R. Schmidt, W. Reutter, S. Hinderlich, and T. Peters
Characterization of Ligand Binding to the Bifunctional Key Enzyme in the Sialic Acid Biosynthesis by NMR: II. INVESTIGATION OF THE ManNAc KINASE FUNCTIONALITY
J. Biol. Chem.,
December 31, 2004;
279(53):
55722 - 55727.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|